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Recognizing Type VII Collagen 
Type VII collagen, a protein of epithelial basement mem~ranes, is 
mposed of a trimer of identical a chains. Each polypeptide has a ~~5-kDa noncollagenous amino-terminal domain and a 145-kDa 
collagenous carboxy-terminal section. In the December 1992 issue 
f this journal, Gammon et al (] Invest Dermatol 99:691-696, ~ 992) reported the isolation and characterization of a cDNA encod-
. g the N-terminal noncollagenous (NC1) portion of type VII col-;~gen. Autoantibodies in serum from a patient with epidermolys!s 
bullosa supplied a handl~ for the ~DNA library screen1l1g stef. TIllS 
lone provided further 1I1formatlon about the structural 'regIOns of ~pe VII collagen. T!le NCI domain contains m~ltiple ta~dem re-
eats of fibronectin-hke sequences as well as a regIOn that b1l1ds type fv collagen and a segment that has homology with von Willebra~d 
factor A. Both epidermolysis bullosa acquisita (EBA) and systemiC 
lupus erythematosus (SLE) are autoimmune blistering disorders. 
Each is characterized by tissue-bound and circulating IgG autoanti-
bodies that react with collagen in the epithelial basement mem-
brane. In this issue Gammon and his colleagues (p. 618) create an 
epitope map of the NCI domain of type VII collagen and determine 
the sites where EBA and SLE autoantibodies interact with the pro-
tein. 
A panel of overlapping cDNA fragments that span the protein 
coding region was subcloned into two different expression vectors. 
Each new clone produced a fusion protein containing one or more 
identified structural elements in N Cl. By Western immunoblot and 
enzyme-linked immunosorbent assays, seven EBA and five SLE pa-
tient sera targeted each fusion protein for autoantibody recognition. 
Because type VII collagen plays a role in lamina densa-dermal 
adhesion, and because alteration of the C017 A-I gene in dystrophic 
forms of EB disrupts formation of anchoring fibrils, the authors 
reasoned that autoantibodies of EBA and SLE might interfere with 
adherence by interacting with different epitopes of type VII colla-
gen. The authors make several interesting points. First, all but one 
(> 90%) of the sera containing type VII collagen antibodies react 
with fusion proteins generated from the NCI domain. Second, most 
sera. recognized at least two regions in the fibronectin-like repeat 
sectIOn. These areas do not share common amino acid sequences and 
are. not cross-reactive, indicating that they are distinct epitopes. 
Third, no antisera reacted unambiguously with the putative colla-
gen binding domain. 
The finding of similar epitope recognition by EBA and SLE au-
toantibodies suggests that differences in the clinical phenotypes of 
these disorders do not result from differences in the sites of the 
colla.gen VII molecule recogniz.ed by the antibodies, and supports 
preViOUS work by the group 1U?ICa~lI1g that functional heterogene-
Ity among collagen VII autoantibodies may influence clinical pheno-
typ~ (J Invest Dermatol 89:478-483, 1987) . The possibility re-
maills ~hat there are fi?e d~fferences in precise peptide sequences 
recogl1lze.d by these ant~b?dles and the group is currently addressing 
thiS question by determmmg which amino acid sequences are recog-
nized by the autoantibodies. 
Another Warning About Alcohol Consumption 
Severe psoriasis has been effectively treated with the aromatic reti-
noid acetretin and its ester, etretinate. The ester is more active and 
more easily absorbed than acetretin; however, it accumulates in 
adipose tissues after chronic administration. Because both com-
pounds are potentially teratogenic, acetretin has been favored for 
treatment of women during their childbearing years because it is 
more rapidly eliminated from the body. Recently, the 2-month 
anticonceptive period following acetretin therapy was extended to 2 
years aft~r some pati~nts showed elevated plasma levels of etretin-
ate. P.rehmmary studies in rats showed that ethanol might act as a 
contnbutll1g factor in the esterification of acetretin in vivo. To clar-
i~y the relationship between plasma levels of these retinoid metabo-
htes. a?d alcohol use, Larsen et al (p. 623) monitored 10 patients 
recelvll1g a 3-month chronic acetretin treatment for psoriasis. Blood 
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